The Beauty Health Company (NASDAQ:SKIN) Receives $1.38 Average PT from Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been given an average recommendation of “Hold” by the seven analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $1.3750.

A number of research analysts have weighed in on the stock. Zacks Research lowered shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. TD Cowen cut their price target on Beauty Health from $1.00 to $0.90 and set a “hold” rating for the company in a report on Wednesday, August 12th. Weiss Ratings downgraded Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, July 23rd. Roth Capital reissued a “buy” rating and set a $2.00 price objective (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th. Finally, Canaccord Genuity Group lowered their price objective on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday, May 1st.

Beauty Health Price Performance

Shares of NASDAQ SKIN opened at $0.67 on Friday. The firm has a 50-day simple moving average of $0.73 and a 200-day simple moving average of $0.88. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36. The stock has a market capitalization of $86.80 million, a price-to-earnings ratio of -3.03 and a beta of 1.07. Beauty Health has a 52 week low of $0.55 and a 52 week high of $2.69.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.02) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.02). Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The firm had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. On average, equities analysts predict that Beauty Health will post -0.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE raised its position in Beauty Health by 19.2% in the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock valued at $95,000 after purchasing an additional 17,088 shares during the period. Renaissance Technologies LLC boosted its position in shares of Beauty Health by 29.6% during the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock worth $253,000 after buying an additional 64,900 shares during the period. Capricorn Fund Managers Ltd purchased a new position in shares of Beauty Health during the first quarter worth $17,270,000. Diversified Trust Co acquired a new stake in shares of Beauty Health in the first quarter valued at $25,000. Finally, Invesco Ltd. grew its stake in shares of Beauty Health by 65.4% in the fourth quarter. Invesco Ltd. now owns 69,422 shares of the company’s stock valued at $96,000 after buying an additional 27,453 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.